Avoid Empiric Fluconazole for Candida auris

October 2019

Your hospital will start preparing for Candida auris...a multidrug-resistant yeast that's reached more than 12 states across the U.S.

C. auris has high mortality...spreads easily among patients...contaminates surfaces...and is tough to eliminate.

Plus few labs are able to identify C. auris yet. It can mistakenly be reported as another yeast...especially Candida haemulonii.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote